Data as of Aug 25, 2026 · Based on 286 AI responses from ChatGPT Search and Google AI Mode · See how Parse measures this
Brands AI recommends here
Named in 44% of answers
Named in 27% of answers
Named in 20% of answers
Named in 17% of answers
Source | Citation share |
|---|---|
 VC Uncapped Rounds - Invest or Avoid Completely?https://lastmoneyin.co/p/vc-uncapped-rounds-invest-avoid-completely | 7.7% |
 Uncapped and Supercapped Notes and SAFEs: Good in Small Doses | SaaStrhttps://www.saastr.com/uncapped-and-supercapped-notes-and-safes-good-in-small-doses/ | 3.2% |
 Uncapped SAFEs: when to use them, no caphttps://www.admnt.com/blog/uncapped-safes-when-to-use-them-no-cap | 2.6% |
 Uncapped Notes | Hustle Fundhttps://www.hustlefund.vc/post/uncapped-notes | 2.4% |
 Startups: Don't Waste Your Time Pitching Without a Valuation ...https://pitchingangels.com/2021/10/12/uncapped-safe-and-notes/ | 2.4% |
 FOUNDERS: stay away from uncapped SAFEs if you’re raising from professional angels or institutional VC firms. | Morgan Polotanhttps://www.linkedin.com/posts/morganpolotan_founders-stay-away-from-uncapped-safes-if-activity-7290042224950542336-mk7h | 2.0% |
Uncapped SAFEs Explained: When Founders Should (and Shouldn’t) Use Themhttps://www.admnt.com/blog/uncapped-safes-explained-when-founders-should-and-shouldnt-use-them | 1.9% |
The Case for Uncapped SAFEs - Last Money Inhttps://lastmoneyin.co/p/the-case-for-uncapped-safes | 1.8% |
 The Case For The Uncapped SAFEhttps://news.crunchbase.com/startups/uncapped-safe-case-gray-equidam/ | 1.7% |
 7 VCs say they are still bullish on SAFE rounds — but not all of themhttps://techcrunch.com/2023/07/19/investors-discuss-safe-rounds/ | 1.6% |
When a startup is a true "hot deal," institutional VCs generally still **dislike pure uncapped SAFEs with only a discount** because it leaves their target ownership percentage entirely unmoored until the next priced round. However, institutional resistance drops significantly under specific conditions—usually when the…
When a startup is a true "hot deal," institutional VCs generally still dislike pure uncapped SAFEs with only a discount because it leaves their target ownership percentage entirely unmoored until the next priced round. However, institutional resistance drops significantly under specific conditions—usually when the uncapped SAFE functions as an instant markup/bridge right right before a massive priced round, or when dealing with highly founder-friendly micro-funds and accelerators.
Instead of specific brand-name VC tier-1 funds that prefer uncapped notes (virtually none do for early discovery), comfort with uncapped structures is categorized by investor type and context:
If you want to tailor your approach, tell me:
I can help you strategize how to pitch this to minimize pushback from incoming checks.
For a **hot deal**, the set of VCs willing to invest on an **uncapped SAFE (or uncapped MFN SAFE)** is much smaller than the set willing to do a normal SAFE. The investors who do it usually fall into one of these buckets: 1. They have extreme conviction and don’t want to lose allocation. 2. They are investing very…
For a hot deal, the set of VCs willing to invest on an uncapped SAFE (or uncapped MFN SAFE) is much smaller than the set willing to do a normal SAFE. The investors who do it usually fall into one of these buckets:
The important distinction: most institutional VCs are not comfortable with a truly uncapped SAFE with no protections. The more common “uncapped” structure is an uncapped MFN SAFE, where the investor gets the best terms of any later SAFE issued before the priced round. YC explicitly uses this structure as part of its standard deal, and it is recognized as a way to defer valuation while preserving some investor protection.
Firms and investor types that are historically more open to these structures:
These firms are generally more comfortable being first institutional money than later-stage funds.
A larger seed fund may accept uncapped if:
The pitch is usually not “please invest without knowing the valuation.” It is:
“We are closing quickly, allocation is limited, and the next financing will establish price. We want you in now.” Some investors view uncapped structures as acceptable when they are effectively buying into a near-certain markup event.
Expect resistance from:
Their concern is straightforward: an uncapped SAFE makes it hard to know what percentage they are buying. A SAFE with a valuation cap gives them a ceiling on conversion price; without one, they are relying on future terms.
A useful question is: “Who is already in the round?” The answer changes the investor list dramatically. If you have YC, a top angel, a known founder, strong traction, or a signed lead, many more VCs become flexible.
If you share your stage (pre-seed/seed), sector, raise size, traction, and whether you already have a lead, I can give you a much tighter list of funds that are realistic targets.
Yes—but there’s an important distinction: **VCs that are comfortable with an uncapped SAFE are usually comfortable because they believe the deal is unusually competitive, not because uncapped SAFEs are standard.** As of 2026, uncapped/no-discount SAFEs are still a small minority of the market. Carta reports that **94%…
Yes—but there’s an important distinction: VCs that are comfortable with an uncapped SAFE are usually comfortable because they believe the deal is unusually competitive, not because uncapped SAFEs are standard.
As of 2026, uncapped/no-discount SAFEs are still a small minority of the market. Carta reports that 94% of post-money SAFEs in H1 2026 had valuation caps, while the uncapped MFN structure is specifically designed for investors willing to defer pricing.
The key is that I'd not pitch this as "Will you invest on an uncapped SAFE?" in isolation. Pitch it as:
"We're closing a fast-moving round on an uncapped MFN SAFE and giving priority to investors who can commit quickly." That changes the psychology considerably.
An uncapped MFN SAFE isn't necessarily founder-friendly if you're going to issue cheaper SAFEs afterward. Under YC's form, the MFN investor can take the favorable terms of subsequent SAFEs.
For example, if someone invests $500K uncapped today and you subsequently sell $2M at a $20M post-money cap, the MFN investor can effectively get the $20M terms. So you're not actually avoiding dilution—you are deferring the valuation negotiation.
That's why the strongest case for an uncapped SAFE is:
Hot company + very short fundraising window + investors competing for allocation + high likelihood that the next SAFE has a substantially higher cap.
If you tell me your stage, amount you're raising, sector, traction (e.g. ARR/users), and approximate check size you're seeking, I can give you a specific 15–25-fund target list of VCs most likely to accept uncapped/MFN paper, ranked by probability.
Raising on an uncapped SAFE with a discount requires massive market leverage—typically reserved for founders with multiple term sheets, repeat founders, or companies with explosive, oversubscribed momentum.[](https://lastmoneyin.co/p/vc-uncapped-rounds-invest-avoid-completely)…
Raising on an uncapped SAFE with a discount requires massive market leverage—typically reserved for founders with multiple term sheets, repeat founders, or companies with explosive, oversubscribed momentum.
While traditional institutional VCs generally dislike uncapped instruments because they lack downside protection and predictable ownership math, certain categories of investors are far more flexible if the deal is hot enough:
If you'd like to narrow this down, tell me:
I can give you advice on how to position this to investors without triggering pushback.
Yes—but **the list is much shorter for a truly uncapped SAFE** than for a capped SAFE. I’d distinguish between **uncapped MFN** and **uncapped + discount**; the latter is substantially easier to sell to institutional investors. ### VCs/investors I’d put at the top of the list 1. **Y Combinator** — the clearest…
Yes—but the list is much shorter for a truly uncapped SAFE than for a capped SAFE. I’d distinguish between uncapped MFN and uncapped + discount; the latter is substantially easier to sell to institutional investors.
Y Combinator — the clearest institutional precedent. YC's current standard deal itself includes $375K on an uncapped MFN SAFE alongside $125K for 7%. That makes YC unusually comfortable with the structure.
Seed-stage VCs that routinely follow YC-style financing — particularly funds whose strategy is to invest very early based on team/product velocity rather than negotiate a precise valuation. I would target these selectively, rather than assume an entire fund is comfortable with uncapped paper.
Founder/operator-led funds and syndicates — probably your highest-probability category if the deal is genuinely hot. The logic is simple: if they're convinced the next financing will be materially higher, they may care more about getting into the company immediately than securing a valuation cap. Recent commentary specifically identifies the "instant markup" situation—an uncapped instrument can make sense when a major financing is already forming/closing.
If by "uncapped note" you mean:
A. Uncapped + no discount + MFN
→ Very founder-friendly, much harder to get from conventional VCs. YC is the major institutional example. YC describes its MFN SAFE as having no cap or discount but picking up the terms of subsequent SAFEs.
B. Uncapped + 10–20% discount
→ Much more VC-friendly. The investor gets protection for being early without forcing you to establish a valuation today. The current YC SAFE docs explicitly support an uncapped/no-cap SAFE structure, and market commentary describes uncapped instruments with a discount as a viable structure when there's strong financing momentum.
C. Uncapped + MFN + discount
→ Probably the best compromise if you're trying to raise quickly from sophisticated investors while preserving upside.
I wouldn't spray 50 VC firms with "will you invest uncapped?" Instead, pitch it as:
"We're moving quickly and don't want to spend two weeks negotiating valuation. We're offering the standard YC post-money SAFE, uncapped MFN, and we're giving priority to investors who can make a decision this week."
That frames the lack of a cap as a speed/access feature, rather than asking the investor to accept worse economics.
Also, uncapped SAFEs are genuinely unusual in the broader market: one recent review citing Carta data says only about 1% of SAFEs were uncapped/no-discount, versus the large majority being capped.
If this is a genuinely hot deal, I can do something more useful: research 20–30 specific U.S. seed VCs and angels and rank them by evidence that they've actually invested on uncapped SAFEs/notes, including check size, stage, sector, and partner to approach.
When a startup is a genuinely **hot deal** (oversubscribed, competitive, or fast-moving), traditional institutional VCs generally *avoid* uncapped notes or SAFEs as a primary investment vehicle. This is because standard fund math requires predictable ownership targets, and an uncapped instrument leaves the investor's…
When a startup is a genuinely hot deal (oversubscribed, competitive, or fast-moving), traditional institutional VCs generally avoid uncapped notes or SAFEs as a primary investment vehicle. This is because standard fund math requires predictable ownership targets, and an uncapped instrument leaves the investor's percentage completely unhedged against a skyrocketing valuation.
However, comfort with uncapped or MFN (Most Favored Nation) SAFEs in a hot deal depends heavily on who is writing the check and why.
If you are trying to push an uncapped instrument on a hot deal, sophisticated institutional funds will usually view it as a red flag or a non-starter unless a priced round is literally hours away.
To help tailor your strategy, tell me:
I can help you decide whether to push for an uncapped structure or switch to a high-cap/discount SAFE that VCs will actually sign.
Yes—but there’s an important distinction: **a truly uncapped, no-discount SAFE is unusual for institutional VCs**. The investors most comfortable with it tend to be investors who either have unusually high conviction in the founder/deal or routinely use **uncapped MFN SAFEs**. A useful current shortlist: | Investor |…
Yes—but there’s an important distinction: a truly uncapped, no-discount SAFE is unusual for institutional VCs. The investors most comfortable with it tend to be investors who either have unusually high conviction in the founder/deal or routinely use uncapped MFN SAFEs.
A useful current shortlist:
| Investor | Comfort with uncapped SAFE | Why |
|---|---|---|
| Y Combinator | Very high | Its current $500K standard deal explicitly includes $375K on an uncapped MFN SAFE. www.ycombinator.com |
| Techstars | Very high | Current terms include $200K on an uncapped MFN SAFE. www.techstars.comwww.ycombinator.com |
| High-conviction seed/pre-seed funds | Medium–high | Some will do uncapped SAFEs when they believe a competitive deal will quickly reach a priced round, but this is partner- and deal-dependent. |
| Traditional institutional seed VCs | Low–medium | Many prefer a cap because an uncapped instrument gives them little protection if the company appreciates dramatically before the next financing. |
| Growth/Series A+ VCs | Low | They generally expect a priced round or at least a valuation framework. |
The strongest signal is actually YC + Techstars: both currently use uncapped MFN instruments themselves, so the concept isn't foreign to sophisticated institutional investors.
I'd approach investors with something like:
“We're raising $X on the standard post-money SAFE, uncapped/no discount. We're limiting the round to $Y and expect to price our seed/A by [rough timeframe].”
The round dynamics matter enormously. An investor may accept an uncapped SAFE if they believe:
There's also a strategic advantage for you: don't volunteer a cap if nobody requires one. Current market data suggests capped-only SAFEs are still the norm, while uncapped/no-discount SAFEs are rare—so an investor accepting yours is giving you a meaningful concession.
“Uncapped” and “uncapped MFN” are very different from the founder's perspective.
With an MFN provision, if you subsequently issue another SAFE with, say, a $15M cap or a 20% discount, the MFN investor can generally take those more favorable terms. That's exactly how YC's and Techstars' current structures work.
If you tell me (1) sector, (2) amount you're raising, (3) rough traction/revenue, (4) stage, and (5) whether you want $250K, $500K, $1M+ checks, I can give you a target list of 15–25 specific VCs that are most plausible for an uncapped SAFE, ranked by likelihood.
In a genuinely hot deal—especially within hyper-competitive sectors like generative AI or infrastructure—traditional institutional VCs rarely invest on a purely **uncapped SAFE** (with or without a small discount) unless specific conditions are met. Because uncapped SAFEs lack a valuation ceiling, they offer no…
In a genuinely hot deal—especially within hyper-competitive sectors like generative AI or infrastructure—traditional institutional VCs rarely invest on a purely uncapped SAFE (with or without a small discount) unless specific conditions are met. Because uncapped SAFEs lack a valuation ceiling, they offer no downside protection or predictable ownership targets for fund managers, meaning standard institutional math usually rejects them.
However, when VCs do agree to uncapped or MFN-only (Most Favored Nation) instruments on a hot deal, it typically falls into a few distinct categories of investors:
To help narrow down who to target, could you share:
Yes—but there’s an important distinction: **uncapped MFN SAFEs are much more accepted by accelerators and very early-stage investors than by traditional institutional VCs.** YC explicitly uses one in its standard deal, and Techstars has used an uncapped MFN SAFE as part of its standard structure.…
Yes—but there’s an important distinction: uncapped MFN SAFEs are much more accepted by accelerators and very early-stage investors than by traditional institutional VCs. YC explicitly uses one in its standard deal, and Techstars has used an uncapped MFN SAFE as part of its standard structure.
For a hot deal where you're trying to avoid setting a cap, I'd prioritize:
But if by "VC" you mean a traditional seed fund writing $500K–$3M checks, I'd be more cautious. A 2026 CRV guide describes uncapped MFN SAFEs as best suited to a short bridge when a priced round is close, and reporting from a group of VCs found several investors explicitly unwilling to do uncapped SAFEs at pre-seed.
The interesting implication for a hot deal is: don't pitch it as "we can't figure out our valuation." Pitch it as "we're moving quickly, have strong demand, and are deliberately deferring price discovery until the next financing." That's much more palatable to an investor who already believes the company is likely to reprice upward.
Also, if you're talking about a purely uncapped, non-MFN SAFE/note, that's a tougher ask. The YC-style uncapped MFN is considerably more defensible because the investor gets the benefit of the best terms you subsequently give another SAFE investor. YC's current documents explicitly include this as a standard SAFE form.
If you tell me your stage, amount you're raising, sector, and rough traction/valuation range, I can give you a target list of ~15 VCs/angels most likely to accept an uncapped SAFE, ranked by likelihood, rather than just the generic names above.
If you truly have a **hot deal** —meaning massive oversubscription, intense FOMO, or a competitive, fast-moving pre-seed/seed round—the typical rules of venture capital shift dramatically in your favor. However, **uncapped SAFEs** (or uncapped notes) are historically unpopular with institutional VCs because they offer…
If you truly have a hot deal —meaning massive oversubscription, intense FOMO, or a competitive, fast-moving pre-seed/seed round—the typical rules of venture capital shift dramatically in your favor. However, uncapped SAFEs (or uncapped notes) are historically unpopular with institutional VCs because they offer no valuation ceiling or downside protection, meaning the investor takes all the pricing risk of a future round without a guaranteed upside.
When VCs do agree to invest on an uncapped SAFE (usually with a discount rate, like 10%–20%), it is almost always under specific conditions and specific types of investors:
What You Need to Know Before Pitching Uncapped:
To help tailor this strategy, could you share:
